DALORIE WILSON: Open Payments
NPI 1144755158 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $266 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $169 |
| Mallinckrodt Hospital Products Inc. | 2 | $162 |
| Ardelyx, Inc. | 1 | $161 |
| Phathom Pharmaceuticals, Inc. | 1 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $38 |
| Janssen Biotech, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
Products named: TERLIVAZ, IBSRELA, Livdelzi, VOQUEZNA, XIFAXAN, TREMFYA, ZENPEP.
Industry payments across FL — which companies pay providers there.
